Reuters logo
BRIEF-Staidson Beijing Biopharmaceuticals sees Q1 FY 2017 net profit up 10 pct to 30 pct
March 21, 2017 / 8:14 AM / in 7 months

BRIEF-Staidson Beijing Biopharmaceuticals sees Q1 FY 2017 net profit up 10 pct to 30 pct

March 21 (Reuters) - Staidson Beijing Biopharmaceuticals Co Ltd :

* Sees Q1 FY 2017 net profit to increase by 10 percent to 30 percent, or to be 60.4 million yuan to 71.4 million yuan

* Says Q1 FY 2016 net profit was 54.9 million yuan

* The reason for the forecast is steady rise in sales of main products

Source text in Chinese: goo.gl/9RStBZ

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below